Cosmos Health (COSM) is entering the final stage of development for CCX0722, its weight management solution. The Company is currently finalizing the scale-up production phase, paving the way for human clinical trials and targeting a market launch in the first or second quarter of 2026. Building on the completion of pilot production and previous development milestones, Cosmos Health is now actively engaging with Contract Research Organizations to complete the technical dossier, and clinical trials are set to be completed between the end of 2025 and the beginning of 2026.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COSM:
- Cosmos Health secures 10-year contract manufacturing order from Provident
- Cosmos Health files patent application for multiple sclerosis treatment
- Cosmos Health secures rights, exclusive licensing for two anticancer drugs
- Cosmos Health secures exclusive distribution agreement with Virax Biolabs
- Cosmos Health appoints Dimitrios Trafalis as head of oncology